Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images

Journal of Nuclear Cardiology

Volumn 10, Issue 1, 2003, Pages 4-8

  Klodas, Elizabeth ^a,b   Miller, Todd D ^a   Christian, Timothy F ^a   Hodge, David O ^a   Gibbons, Raymond J ^a  

^a MAYO CLINIC   (United States)

^b Center For Diagnostic Imaging Minnesota   (United States)

Author keywords

Computed tomography; Electrocardiography; Prognosis; Single photon emission; Vasodilator stress

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; ESTROGEN; LONG ACTING DRUG; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; THALLIUM 201;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; AUTOPSY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0037226111     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2003.127624     Document Type: Article

References (37)

1. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. [see comments] Circulation 1991;83:363-81.
2. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.
3. Pamelia FX, Gibson RS, Watson DD, Craddock GB, Sirowatka J, Beller GA. Prognosis with chest pain and normal thallium-201 exercise scintigrams. Am J Cardiol 1985;55:920-6.
4. Wackers FJT, Russo DJ, Russo D, Clements JP. Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. J Am Coll Cardiol 1985;6:27-30.
5. Raiker K, Sinusas AJ, Wackers FJT, Zaret BL. One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium 99m-labeled sestamibi exercise imaging. J Nucl Cardiol 1994;1:449-56.
6. Krishnan R, Lu J, Daw MW, Botvinick EH. Does myocardial perfusion scintigraphy demonstrate clinical usefulness in patients with markedly positive exercise tests? An assessment of the method in a high-risk subset. Am Heart J 1994;127:804-16.
7. Gibbons RJ, Hodge DO, Berman DS, Akinboboye OO, Heo J, Hachamovitch R, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;100:2140-5.
8. Hendel RC, Layden JL, Leppo JA. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990;15:109-16.
9. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647-52.
10. Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo C, McClellan JR. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995;26:1202-8.
11. Lette J, Bertrand C, Gossard D, Ruscito O, Cerino M, McNamara D, et al. Long-term risk stratification with dipyridamole imaging. Am Heart J 1995;129:880-6.
12. Hachamovitch R, Berman DS, Kiat H, Cohen I, Lewin HC, Ammanullah AM, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80:426-33.
13. Iskandrian AS, Heo J, Lemlek J, Ogilby JD, Untereker WJ, Iskandrian B, et al. Identification of high risk patients with left main and three vessel coronary artery disease by adenosine single photon emission computed tomographic thallium imaging. Am Heart J 1993;125:1130-5.
14. Hart CY, Miller TD, Hodge DO, Gibbons RJ. Specificity of the stress electrocardiogram during adenosine myocardial perfusion imaging in patients taking digoxin. Am Heart J 2000;140:937-40.
15. Ho KT, Miller TD, Christian TF, Hodge DO, Gibbons RJ. Prediction of severe coronary artery disease and long-term outcome in patients undergoing vasodilator SPECT. J Nucl Cardiol 2001;8:438-44.
16. Hendel RC, Whitfield SS, Villegas BJ, Cutler BS, Leppo JA. Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol 1992;70:1243-9.
17. Marshall ES, Raichlen JS, Kim SM, Intenzo CM, Sawyer DT, Brody EA, et al. Prognostic significance of ST-segment depression during adenosine perfusion imaging. Am Heart J 1995;130:58-66.
18. Chambers CE, Brown KA. Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants. J Am Coll Cardiol 1988;12:37-41.
19. Villanueva FS, Smith WH, Watson DD, Beller GA. ST-segment depression during dipyridamole infusion, and its clinical, scintigraphic and hemodynamic correlates. Am J Cardiol 1992;69:445-8.
20. Marshall ES, Raichlen JS, Tighe DA, Paul JJ, Breuninger KM, Chung EK. ST-segment depression during adenosine infusion as a predictor of myocardial ischemia. Am Heart J 1994;127:305-11.
21. Diamond GA. A clinically relevant classification of chest discomfort. [letter] J Am Coll Cardiol 1983;1(2 Pt 1):574-5.
22. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300:1350-8.
23. Gibbons RJ, Zinsmeister AR, Miller TD, Clements IP. Supine exercise electrocardiography compared with exercise radionuclide angiography in noninvasive identification of severe coronary artery disease [see comments]. Ann Intern Med 1990;112:743-9.
24. Christian TF, Miller TD, Bailey KR, Gibbons RJ. Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging. Am J Cardiol 1992;70:14-20.
25. Johnston DL, Daley JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients. Mayo Clin Proc 1995;70:331-6.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
27. Virtanen KS, Mattila S, Jarvinen A, Frick MH. Angiographic findings in patients exhibiting ischemia after oral dipyridamole. Int J Cardiol 1989;23:33-6.
28. Nishimura S, Mahmarian JJ, Bouce TM. Angiographic and hemodynamic determinants of myocardial ischemia during adenosine thallium-201 scintigraphy in coronary artery disease. Circulation 1993;87:1211-9.
29. Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee VW. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;310:1014-8.
30. Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 1985;312:389-94.
31. Kamal AM, Fattah AA, Pancholy SB, Aksut S, Cave V, Heo J, et al. Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1994;1:254-61.
32. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography [published erratum appears in J Am Coll Cardiol 1996;27:756]. J Am Coll Cardiol 1995;26:639-47.
33. Bateman TM, O'Keefe JHJ, Dong VM, Barnhart C, Ligon RW. Coronary angiographic rates after stress single-photon emission computed tomography. J Nucl Cardiol 1995;2:217-23.
34. Nallamothu N, Pancholy SB, Lee KR, Heo J, Iskandrian AS. Impact on exercise single-photon emission computed tomographic thallium imaging on patient management and outcome. J Nucl Cardiol 1995;2:334-8.
35. He ZX, Cwajg E, Hwang W, Hartley CJ, Funk E, Michael LH, et al. Myocardial blood flow and myocardial uptake of 201-T1 and 99m-Tc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A2A receptor agonist. Circulation 2000;102:438-44.
36. Al Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
37. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6.